A glaucoma drainage tube is provided. The glaucoma drainage tube is a glaucoma drainage tube for draining aqueous humor, and includes a canal through which the aqueous humor flows, and a displacement member that is arranged at an inlet of the canal and is displaced so as to reciprocate in response to a flow of the aqueous humor flowing therein.

The present disclosure relates to an injection device, in particular a micro dose injection device such as, for example, an ophthalmic injection device. An example device comprises a rotatable plunger; a solution receptacle having a first end configured to slidably receive the rotatable plunger and a second end configured to dispense solution contained in the solution receptacle; a first stop member configured to prevent the rotatable plunger from being slidably displaced to a second position while the rotatable plunger is at a first position and in a first orientation; and a second stop member configured to prevent the rotatable plunger from rotating in a first direction about the first axis while the rotatable plunger is at the first position and in the first orientation, wherein slidably displacing the rotatable plunger from the first position to the second position dispenses a quantity of the solution contained in the solution receptacle.

A system and method for providing sensory relief from distractibility, inattention, anxiety, fatigue, and/or sensory issues to a user in need. The user can be autistic/neurodiverse, or neurotypical. The system can be configured to connect to a datastore storing one or more sensory thresholds specific to a user of a wearable device of the system, the sensory thresholds selected from auditory, visual or physiological sensory thresholds; record, using one or more sensors of the wearable device, a sensory input stimulus to the user; compare the sensory input stimulus with the sensory thresholds to determine an intervention to be provided to the user, the intervention configured to provide the user relief from distractibility, inattention, anxiety, fatigue, or sensory issues; and provide the intervention to the user, the intervention comprising filtering, in real-time, an audio signal presented to the user or an optical signal presented to the user.

Provided is an ophthalmic instrument that is for retaining a tube member for providing communication between the inside and the outside of an eyeball, such that the tube member is stuck into an outer membrane of the eyeball and that is suitable for retaining the tube member at an outer peripheral portion of a cornea. An ophthalmic instrument includes a main body and a needle portion connected to the main body. The main body has a straight portion and a bent portion. When attaching a tube member to an eyeball, first, the needle portion is inserted through the tube member, and the tube member is stuck into an outer peripheral portion of a cornea as the outer membrane of the eyeball while a hole is made in the outer peripheral portion of the cornea with the needle portion.

Injection devices for delivering pharmaceutical compositions into the eye are described. Some devices include a resistance component for controllably deploying an injection needle through the eye wall. The resistance component may be disposed on the injector device, or on a portion of the injection device housing, or on a drug reservoir. Some devices may be removably attached to a drug reservoir, for example, through a luer connector. Other devices may comprise internal luer seal for securely connecting a drug conduit of the device to the luer cavity of a drug reservoir. Yet other devices may comprise a priming-enabling element to facilitate the drug priming of a shielded needle. Related methods and systems comprising the devices are also described.

Systems and methods are provided for identifying a therapeutic VR activity or exercise for a subject/patient based on the subject's impairments, dynamically adjusting a VR activity for a patient, and identifying potential impairments based on a patient's performance in a VR activity. Patients may each have various physical, neurological, cognitive, and/or sensory impairments to be treated. Not all therapeutic activities may be appropriate for some patients and their impairments. A VR therapeutic activity platform may increase patient engagement and challenge patients at more appropriate times by better matching activities corresponding to a patient's impairments and dynamically adjusting each VR activity based on performance to offer a challenging and rewarding therapeutic experience.

The invention is directed to an eye cover for maintaining eye closure during sleep or for daytime wear for certain eye conditions. The eye cover is sized and shaped so as to fit within the orbit of the patient's eye rather than around the orbit. By fitting closely within the orbit of the eye, the eye cover is much less likely to be disturbed or dislodged during movement over the course of a night's sleep. The eye cover further is porous and includes fenestrations to provide for the passage of air to the eye.

A fluid dispensing device includes a light source, and a nozzle spaced from the light source. The device also includes a membrane positioned within a beam path of the light source, where the membrane is configured to allow a portion of light from the light source through to the nozzle. The device also includes a fluid chamber positioned between the membrane and the nozzle, where the nozzle is configured to allow a beam of the portion of light to pass through along the beam path, and where the nozzle is further configured to form a stream of fluid expelled from the fluid chamber along the beam path.

A device for injecting a therapeutic agent into an ocular implant at least partially implanted in an eye including an injection lumen providing a pathway for injecting the therapeutic agent into the implant; an outlet lumen providing a pathway for pre-existing fluid in the ocular implant to exit the implant; and a collection chamber fluidly coupled to the outlet lumen that provides a first fluid outflow resistance and a second fluid outflow resistance. The first fluid outflow resistance is lower than a first resistance to outflow of the implant. The second fluid outflow resistance is greater than a force imparted onto the implant by intraocular pressure of the eye. Injection of therapeutic agent into the implant via the injection lumen causes the pre-existing fluid to exit the implant and enter the collection chamber via the outlet lumen and causes a second pre-existing fluid to displace from the collection chamber.

The present invention discloses a disposable negative-pressure anterior chamber Paracentesis syringe which belongs to the technical field of medical supplies. It comprises nine parts, including a needle cap, a Paracentesis syringe, a needle base, an internal needle, a protective cover of the internal needle, an airlock, a needle tube, a collection tube and a collection tube rack. The invention has the advantages that it fixes the Paracentesis syringe during puncture and limits the depth of the needle insertion, releases the aqueous humor slowly to prevent a sudden drop of the intraocular pressure, reduces the risk of the intraocular infection by separating the anterior chamber from outside and the collection tube can collect and store the aqueous humor directly.